2017
DOI: 10.1016/j.yrtph.2017.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Classification schemes for carcinogenicity based on hazard identification serve science and society

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…36 Some of the current controversy over IARC's classification schemes for carcinogenicity is due to ambiguity in public understanding of hazard versus risk. [39][40][41] An agent is considered a cancer hazard if it is capable of causing cancer under some circumstances. The Monographs Programme may identify cancer hazards even when risks are very low with known patterns of use or exposure.…”
Section: Discussionmentioning
confidence: 99%
“…36 Some of the current controversy over IARC's classification schemes for carcinogenicity is due to ambiguity in public understanding of hazard versus risk. [39][40][41] An agent is considered a cancer hazard if it is capable of causing cancer under some circumstances. The Monographs Programme may identify cancer hazards even when risks are very low with known patterns of use or exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Although a monograph elaborated by a group of experts adds to the literature available for decision makers, the purpose and usefulness of cancer hazard-based classification categories remain unclear. In a response to a criticism about the IARC classification scheme (Boobis et al, 2016), experts from the agency staff (Loomis et al, 2017) argued that hazard identification provides "..a vital platform for the subsequent steps of risk assessment and management". There is no doubt that hazard identification is the initial step of risk assessment and management.…”
Section: Discussionmentioning
confidence: 99%
“…The disagreement between the IARC and regulatory agencies over the carcinogenicity of GLY was promptly echoed by many experts in academia and industry, and gave rise to reviews, letters and position papers (Boobis et al, 2016;Portier et al, 2016;Loomis et al, 2017;Portier, Clausing, 2017;Tarazona et al, 2017a;.…”
Section: The Emergence Of the Controversy On Glyphosate Carcinogenicitymentioning
confidence: 99%